Related Experiment Video
Updated: Apr 26, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Chryseobacterium indologenes Septicemia in an Infant
Turkan Aydin Teke1, Fatma Nur Oz1, Ozge Metin1
1Dr. Sami Ulus Maternity and Children's Research and Training Hospital, Division of Pediatric Infectious Diseases, No. 44, Altındağ, 06080 Ankara, Turkey.
Insights
Chryseobacterium indologenes is a rare bacterial infection in children, often affecting hospitalized patients with severe conditions. Trimethoprim sulfamethoxazole effectively treated a case of nosocomial septicemia caused by this organism in an infant.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Microbiology
- Antimicrobial Resistance
Background:
- Chryseobacterium indologenes is an infrequent pathogen, primarily causing infections in immunocompromised pediatric patients.
- Limited antimicrobial susceptibility of C. indologenes complicates treatment decisions.
- Nosocomial infections pose a significant challenge in pediatric intensive care settings.
Purpose of the Study:
- To report a case of Chryseobacterium indologenes septicemia in an infant with congenital heart disease.
- To evaluate the efficacy of trimethoprim sulfamethoxazole in treating C. indologenes infections.
- To review existing literature on pediatric C. indologenes infections.
Main Methods:
- Case presentation of an infant with congenital heart disease and C. indologenes septicemia.
- Retrospective review of 14 additional pediatric cases from English literature.
- Antimicrobial susceptibility testing and treatment outcome analysis.
Main Results:
- Successful treatment of infant septicemia with trimethoprim sulfamethoxazole.
- C. indologenes infections are associated with significant underlying comorbidities in children.
- Variable antimicrobial sensitivities reported across reviewed cases.
Conclusions:
- Trimethoprim sulfamethoxazole can be an effective therapeutic option for Chryseobacterium indologenes infections in children.
- Early diagnosis and appropriate antimicrobial selection are crucial for managing C. indologenes.
- Further research is needed to understand the epidemiology and optimal treatment strategies for C. indologenes in pediatric populations.
Abstract:
Chryseobacterium indologenes is a rare cause of infection in children. The organism causes infections mostly in hospitalised patients with severe underlying diseases. The choice of an effective drug for the treatment of infections due to C. indologenes is difficult as the organism has a limited spectrum of antimicrobial sensitivity. We present a case of nosocomial septicemia caused by C. indologenes in an infant with congenital heart disease who was successfully treated with trimethoprim sulfamethoxazole and also reviewed fourteen additional cases of C. indologenes infections reported in the English literature in this report.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Gastroenteritis
Bacterial Meningitis II: Pathophysiology
Cholera
Bacterial Phylum Chlamydiae
Acute Pyelonephritis II: Diagnostic Studies and Management

